Li, Pengxiang
Prajapati, Girish
Geng, Zhi
Ladage, Vrushabh P.
Arduino, Jean Marie
Watson, Dovie L.
Gross, Robert
Doshi, Jalpa A.
Funding for this research was provided by:
Merck (Merck)
Article History
Accepted: 5 October 2023
First Online: 27 October 2023
Declarations
:
: This study was funded by Merck Sharp & Dohme LLC, a subsidiary of Merck & Co., Inc., Rahway, NJ, USA. JAD reports serving as a consultant and/or advisory board member for Abbvie/Allergan, Acadia, Janssen, Merck, Otsuka, and Takeda and has received research funding from Janssen, Regeneron, and Spark Therapeutics, all unrelated to this study. PL, ZG, VL, and DW have no relevant disclosures to report. GP and JMA are employees of Merck Sharp & Dohme LLC, a subsidiary of Merck & Co., Inc., Rahway, NJ, USA and own stock in Merck & Co., Inc., Rahway, NJ, USA. RG serves on a DSMB for Pfizer medication trials unrelated to HIV.